Skip to content

TECNIS SIMPLICITY DIB00 (REF DIB00U0300)Recalls & reported problems

Johnson & Johnson Surgical Vision, Inc. · TECNIS SIMPLICITY TECNIS EYHANCE U 30.0D · Class 3 · Implant

All models of TECNIS SIMPLICITY (112)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 05050474731967), received between Apr 14, 2023 and Aug 14, 2024 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Crack” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Appropriate Device Problem Term/Code Not Available1
  • Crack1
  • Device Damaged Prior to Use1
  • Manufacturing, Packaging or Shipping Problem1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2
  • Blurred Vision1
  • Halo1
  • Visual Disturbances1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 14, 2024Device Damaged Prior to Use; Manufacturing, Packaging or Shipping Problem; Appropriate Device Problem Term/Code Not Available; Device Damaged Prior to Use; Manufacturing, Packaging or Shipping Problem; Appropriate Device Problem Term/Code Not Available

    IT IS REPORTED THAT THE PRELOADED MONOFOCAL INTRAOCULAR LENS (IOL), A DIB00 30.0, APPEARED TO BE DAMAGED WITH SOMETHING SPILLED ON IT AND DRIED. THERE WAS NO PATIENT CONTACT. FURTHER INFORMATION SUGGESTS THAT IT LOOKED LIKE A CAN OF SODA WAS SPILLED ON THE LENS. ADDITIONALLY, THE OUTER SHIPPING BOX APPEARED TO HAVE BEEN REPACKAGED. NO FURTHER INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19986812 ↗
  • MalfunctionMay 8, 2023Crack; Crack

    IT WAS REPORTED THAT DURING IMPLANTATION OF AN INTRAOCULAR LENS (IOL) INTO A PATIENT¿S FIST EYE, THE BEVEL APPEARED MISSHAPEN, CARTRIDGE TIP WAS DEFORMED/CRACKED; HOWEVER, THE SURGEON WAS ABLE TO SUCCESSFULLY DELIVER/IMPLANT THE LENS WITHOUT INCIDENT. THERE WAS CONTACT WITH PATIENT¿S EYE. NO FURTHER ATTENTION WAS NEEDED, NO DELAY REPORTED, NO SUTURES REQUIRED, AND IT WAS CONFIRMED THAT THE DIRECTIONS WERE FOLLOWED. THERE WAS NO PATIENT INJURY, NO IMPAIRMENT AND THE ISSUE DID NOT AFFECT PATIENT¿S DAILY ACTIVITIES. THE LENS REMAINS IMPLANTED. NO FURTHER INFORMATION WAS PROVIDED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16891956 ↗
  • InjuryApr 14, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT DIB00 INTRAOCULAR LENS WAS IMPLANTED. THE PATIENT IS ESSENTIALLY PLANO AND 20/20 IN EACH EYE AND HAPPY THAT HE DID SURGERY BUT PERSISTENTLY BOTHERED A 360 DEGREE MID PERIPHERAL HALO/DISTORTION EFFECT IN EACH EYE. IT GOES AWAY WITH SUNGLASSES. THE PATIENT WAS ALSO BOTHERED BY ARTIFICIAL LIGHTING IN ANY SCENARIO, NATURAL LIGHT SEEMS TO BE OK. ADDITIONAL INFORMATION STATED THAT PATIENT HAD MIDPERIPHERAL 360 DEGREE DISTORTION, BLURRINESS AROUND THE EDGES OF THINGS, LIGHT SENSITIVITY WITH ARTIFICIAL AND INDOOR LIGHTING AND DAILY ACTIVITIES ARE SIGNIFICANTLY AFFECTED. PATIENTS PRE OP BEST CORRECED VISUAL ACUITY (BCVA) WAS 20/20 OU, POST-OP UNCORRECTED AND BEST CORRECTED VISUAL ACUITY, POST OP VASC WAS 20/25 AND 20/20, BCVA WAS 20/20 OU. UPON FURTHER FOLLOW UP, IT WAS INFORMED THAT PATIENT HAD REPEATED SHORT TREATMENT WITH PREDNISOLONE PHOSPHATE/BROMFENAX COMBINATION DROP TID X 1 WEEK, THEN TWICE A DAY FOR 1 WEEK (NO APPARENT EFFECT). PATIENT HAS PERSISTENT SYMPTOMS, RECOMMENDED TRIAL OF VUITY BUT NOT CLEAR IF PATIENT HAS PICKED UP, DUE BACK IN CLINIC AT THE TIME OF THIS REPORT. NO OTHER INFORMATION WAS PROVIDED.

    Patient problems: Blurred Vision; Halo; Visual Disturbances

    MAUDE report 16748013 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page